BACKGROUND: HIV-infected (HIV+) donor to HIV+ recipient (HIV D+/R+) transplantation might improve access to transplantation for people living with HIV. However, it remains unknown whether transplant candidates living with HIV will accept the currently unknown risks of HIV D+/R+ transplantation. METHODS: We surveyed transplant candidates living with HIV from 9 US transplant centers regarding willingness to accept HIV+ donor organs. RESULTS: Among 116 participants, the median age was 55 years, 68% were men, and 78% were African American. Most were willing to accept HIV+ living donor organs (87%), HIV+ deceased donor organs (84%), and increased infectious risk donor organs (70%). Some (30%) were concerned about HIV superinfection; even among these respondents, 71% were willing to accept an HIV D+ organ. Respondents from centers that had already performed a transplant under an HIV D+/R+ transplantation research protocol were more willing to accept HIV+ deceased donor organs (89% vs. 71%, P = 0.04). Respondents who chose not to enroll in an HIV D+/R+ transplantation research protocol were less likely to believe that HIV D+/R+ transplantation was safe (45% vs. 77%, P = 0.02), and that HIV D+ organs would work similar to HIV D- organs (55% vs. 77%, P = 0.04), but more likely to believe they would receive an infection other than HIV from an HIV D+ organ (64% vs. 13%, P < 0.01). CONCLUSIONS: Willingness to accept HIV D+ organs among transplant candidates living with HIV does not seem to be a major barrier to HIV D+/R+ transplantation and may increase with growing HIV D+/R+ transplantation experience.
BACKGROUND: HIV-infected (HIV+) donor to HIV+ recipient (HIV D+/R+) transplantation might improve access to transplantation for people living with HIV. However, it remains unknown whether transplant candidates living with HIV will accept the currently unknown risks of HIV D+/R+ transplantation. METHODS: We surveyed transplant candidates living with HIV from 9 US transplant centers regarding willingness to accept HIV+ donor organs. RESULTS: Among 116 participants, the median age was 55 years, 68% were men, and 78% were African American. Most were willing to accept HIV+ living donor organs (87%), HIV+ deceased donor organs (84%), and increased infectious risk donor organs (70%). Some (30%) were concerned about HIV superinfection; even among these respondents, 71% were willing to accept an HIV D+ organ. Respondents from centers that had already performed a transplant under an HIV D+/R+ transplantation research protocol were more willing to accept HIV+ deceased donor organs (89% vs. 71%, P = 0.04). Respondents who chose not to enroll in an HIV D+/R+ transplantation research protocol were less likely to believe that HIV D+/R+ transplantation was safe (45% vs. 77%, P = 0.02), and that HIV D+ organs would work similar to HIV D- organs (55% vs. 77%, P = 0.04), but more likely to believe they would receive an infection other than HIV from an HIV D+ organ (64% vs. 13%, P < 0.01). CONCLUSIONS: Willingness to accept HIV D+ organs among transplant candidates living with HIV does not seem to be a major barrier to HIV D+/R+ transplantation and may increase with growing HIV D+/R+ transplantation experience.
Authors: Jordana B Cohen; Jayme E Locke; Brittany Shelton; Rhiannon D Reed; Margaux Mustian; Paul MacLennan; Kimberly A Forde; Peter P Reese; Deirdre Sawinski Journal: Clin Transplant Date: 2019-01-12 Impact factor: 2.863
Authors: Philippe Selhorst; Catharina E Combrinck; Kathryn Manning; Francois C J Botha; Jan P L Labuschagne; Colin Anthony; David L Matten; Autumn Breaud; William Clarke; Thomas C Quinn; Andrew D Redd; Carolyn Williamson; Elmi Muller Journal: N Engl J Med Date: 2019-10-03 Impact factor: 91.245
Authors: Bonnie E Lonze; Nabil N Dagher; Minghao Liu; Lauren M Kucirka; Christopher E Simpkins; Jayme E Locke; Niraj M Desai; Andrew M Cameron; Robert A Montgomery; Dorry L Segev; Andrew L Singer Journal: Arch Surg Date: 2011-11
Authors: Nir Uriel; Nadav Nahumi; Paolo C Colombo; Melana Yuzefpolskaya; Susan W Restaino; Jason Han; Sunu S Thomas; Arthur R Garan; Hiroo Takayama; Donna M Mancini; Yoshifumi Naka; Ulrich P Jorde Journal: J Heart Lung Transplant Date: 2014-05-09 Impact factor: 10.247
Authors: Sarah E Van Pilsum Rasmussen; Mary Grace Bowring; Ashton A Shaffer; Macey L Henderson; Allan Massie; Aaron A R Tobian; Dorry L Segev; Christine M Durand Journal: Clin Transplant Date: 2018-08-31 Impact factor: 2.863
Authors: Ashley J Limkemann; Luke Wolfe; Amit Sharma; Anne L King; Martha Behnke; Mili Jay Shah; Marc P Posner; Adrian H Cotterell; Chandra S Bhati; Ankur Gupta; Dhiren Kumar; Gaurav Gupta Journal: Clin Transplant Date: 2016-06-27 Impact factor: 2.863
Authors: Zachary Predmore; Brianna Doby; Debra G Bozzi; Christine Durand; Dorry Segev; Jeremy Sugarman; Aaron A R Tobian; Albert W Wu Journal: AIDS Care Date: 2021-06-28
Authors: Shanti Seaman; Diane Brown; Ann Eno; Sile Yu; Allan B Massie; Aaron A R Tobian; Christine M Durand; Dorry L Segev; Albert W Wu; Jeremy Sugarman Journal: J Patient Rep Outcomes Date: 2021-03-18
Authors: Sarah E Van Pilsum Rasmussen; Shanti Seaman; Morgan A Johnson; Karen Vanterpool; Diane M Brown; Aaron A R Tobian; Timothy Pruett; Varvara Kirchner; Faith E Fletcher; Burke Smith; Sonya Trinh; Dorry L Segev; Christine M Durand; Jeremy Sugarman Journal: Transplant Direct Date: 2021-08-06